Limited thymectomy as a potential alternative treatment option for early-stage thymoma: A multi-institutional propensity-matched study

被引:30
作者
Narm, Kyoung Shik [1 ]
Lee, Chang Young [1 ]
Do, Young Woo [1 ]
Jung, Hee Suk [1 ]
Byun, Go Eun [1 ]
Lee, Jin Gu [1 ]
Kim, Dae Joon [1 ]
Hwang, Yoohwa [2 ]
Park, In Kyu [2 ]
Kang, Chang Hyun [2 ]
Kim, Young Tae [2 ]
Cho, Jong Ho [3 ]
Choi, Yong Soo [3 ]
Kim, Jhingook [3 ]
Shim, Yong Mog [3 ]
Hwang, Su Kyung [4 ]
Kim, Yong-Hee [4 ]
Kim, Dong Kwan [4 ]
Park, Seung-Il [4 ]
Chung, Kyung Young [1 ]
机构
[1] Yonsei Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea
[3] Sungkyunkwan Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Samsung Med Ctr, Seoul, South Korea
[4] Univ Ulsan, Coll Med, Dept Thorac & Cardiovasc Surg, Asan Med Ctr, Seoul, South Korea
关键词
Thymoma; Thymomectomy; Thymectomy; Limited thymectomy; Complete thymectomy; Recurrence; MYASTHENIA-GRAVIS; MULTIPLE THYMOMA; MANAGEMENT; RESECTION; SYSTEM;
D O I
10.1016/j.lungcan.2016.06.021
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: For early-stage thymoma, complete thymectomy has classically been regarded as the standard treatment protocol. However, several studies have shown that limited thymectomy may be an alternative treatment option for thymoma. This study compared perioperative outcomes, survival, and recurrence rates between patients undergoing limited thymectomy and complete thymectomy. Materials and methods: Between January 2000 and December 2013, a total of 762 patients underwent thymectomy for stage I or II thymomas at four institutions participating in the Korean Association for Research on the Thymus. Patients were divided into two groups: limited thymectomy group (n = 295) and complete thymectomy group (n = 467). Comparative clinicopathological, surgical, and oncological features were reviewed retrospectively. Results: The median follow-up time was 49 months (range: 0.2-189 months). A propensity score matching analysis, based on seven variables (age, sex, surgical approach, tumor size, WHO histological type, Masaoka-Koga stage, and adjuvant radiotherapy), was performed using 141 patients selected from each group. The 5- and 10-year freedom-from-recurrence rates in the limited thymectomy group were 96.3% and 89.7%, respectively, and those in the complete thymectomy group were 97.0% and 85.0%, respectively. No significant differences in these rates were observed between groups (p = 0.86). A multivariate Cox regression analysis showed that overall survival and freedom-from-recurrence rates did not significantly differ by surgery extent (p = 0.27, 0.66, respectively). Perioperative outcomes were better in the limited thymectomy group. Conclusion: Limited thymectomy was not inferior to complete thymectomy with respect to recurrence, and had better perioperative outcomes. Limited thymectomy may be a viable treatment option for early stage thymoma. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:22 / 27
页数:6
相关论文
共 26 条
  • [1] Recurrence after thymoma resection according to the extent of the resection
    Bae, Mi Kyung
    Lee, Seok Ki
    Kim, Ha Yan
    Park, Seong Yong
    Park, In Kyu
    Kim, Dae Joon
    Chung, Kyung Young
    [J]. JOURNAL OF CARDIOTHORACIC SURGERY, 2014, 9
  • [2] The Management of Thymoma: A Systematic Review and Practice Guideline
    Falkson, Conrad B.
    Bezjak, Andrea
    Darling, Gail
    Gregg, Richard
    Malthaner, Richard
    Maziak, Donna E.
    Yu, Edward
    Smith, Christopher A.
    McNair, Sheila
    Ung, Yee C.
    Evans, William K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (07) : 911 - 919
  • [3] Thymoma A Focus on Current Therapeutic Management
    Girard, Nicolas
    Mornex, Francoise
    Van Houtte, Paul
    Cordier, Jean-Francois
    van Schil, Paul
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (01) : 119 - 126
  • [4] Standard Outcome Measures for Thymic Malignancies
    Huang, James
    Detterbeck, Frank C.
    Wang, Zuoheng
    Loehrer, Patrick J., Sr.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : 2017 - 2023
  • [5] Ito M, 1992, Nihon Kyobu Geka Gakkai Zasshi, V40, P189
  • [6] KOGA K, 1994, PATHOL INT, V44, P359
  • [7] Myasthenia gravis appearing after thymectomy for thymoma
    Kondo, K
    Monden, Y
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2005, 28 (01) : 22 - 25
  • [8] State-of-the-art classification and multimodality treatment of malignant thymoma
    Koppitz, Hannah
    Rockstroh, Juergen K.
    Schueller, Heinrich
    Standop, Jens
    Skowasch, Dirk
    Mueller-Hermelink, Hans Konrad
    Schmidt-Wolf, Ingo G. H.
    [J]. CANCER TREATMENT REVIEWS, 2012, 38 (05) : 540 - 548
  • [9] THYMOMA - RESULTS OF 241 OPERATED CASES
    MAGGI, G
    CASADIO, C
    CAVALLO, A
    CIANCI, R
    MOLINATTI, M
    RUFFINI, E
    [J]. ANNALS OF THORACIC SURGERY, 1991, 51 (01) : 152 - 156
  • [10] Staging System of Thymoma
    Masaoka, Akira
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2010, 5 : S304 - S312